Clinical Trials Logo
  1. Home
  2. Amphetamine Use Disorders
  3. NCT03736317

Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorder

Amphetamine Use Disorders Clinical Trial

Official title:
Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Craving in Methamphetamine Use Disorder

Clinical Trial Summary

Repetitive transcranial magnetic stimulation (rTMS) was used to treat methamphetamine use disorder in previous studies, while the evidence-based protocols still required. The aim of this research is to develop more applicable rTMS intervention pattern and protocols to reduce craving and relapse of methamphetamine-dependent patients.

Clinical Trial Description

The limbic circuit and executive control circuit are two important frontal-striatal neural circuits associated with drug dependence. Previous studies showed increased functional activity within the limbic neural circuit (e.g. medial prefrontal cortex (mPFC) and ventral striatum) in the presence of a salient cue and decreased activity in the executive control circuit (e.g. dorsal prefrontal cortex and dorsal striatum). TMS was used to reverse the activities of these two circuits, by using continuous TBS and intermittent TBS, respectively. In this study, vmPFC cTBS was conducted to modulating the limbic circuit, while left dlPFC iTBS was conducted to modulating the executive control circuit. Combined treatment of vmPFC cTBS and left dlPFC iTBS was conducted to modulating two circuits simultaneously. Focused on evaluating the efficacy of the interventions and investigate the mechanisms, neuropsychological tests, biochemical tests, and electroencephalography will be used to investigate the neurobiological mechanism of the methamphetamine use disorder, craving, and relapse. The study will be very helpful to develop evidence-based rTMS protocols for methamphetamine-dependent patients in clinical practice and decrease harm for both the patients and their families. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03736317
Study type Interventional
Source Shanghai Mental Health Center
Contact
Status Completed
Phase N/A
Start date September 1, 2019
Completion date September 1, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06165198 - Individualized Neuromodulation for the Core Clinical Features of Drug Addiction N/A
Recruiting NCT06457230 - Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the Frontopolar-Cerebellum N/A
Completed NCT03382379 - Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder Phase 1/Phase 2
Completed NCT03922646 - Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder N/A
Not yet recruiting NCT06454474 - Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction N/A
Completed NCT02881177 - Oxytocin HIV Meth Study Phase 1
Recruiting NCT06457243 - Closed-loop cTBS for the Core Clinical Features of Methamphetamine Use Disorder N/A